InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by DAVIS A BRIAN, Chief Financial Officer. Director active across 1 companies, notably Verrica Pharmaceuticals Inc.. In total, 2 filings have been logged. Total volume traded: €82k. The latest transaction was filed on 4 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€40,7575,000 shares@ €8.1513100.0% of flow
Common Stock
SEC:0001209191-21-038480·
Ideal exit: 1 Mar 2022 (T+270)
€40,7575,000 shares@ €8.15130.038% mcap50.0% of flow
Common Stock
SEC:0001209191-21-038480:0·
Ideal exit: 1 Mar 2022 (T+270)
2 of 2 declarations
About DAVIS A BRIAN
Brian A. Davis is the Chief Financial Officer at Verrica Pharmaceuticals Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. Davis plays a crucial role in financial strategy.
